HEAD OF DRUG SUBSTANCE (SR), HEAD OF DRUG DELIVERY & PRODUCT (PS), EVONIK HEALTH CARE
"The US leads innovation, so if you are not heavily invested there in pharma, you are in trouble. Lots of our clients are shifting their production from Asia, so the US will remain critical to Evonik Health Care’s growth."
"We produce approximately 7% of the global vanadium supply, and on the titanium side, we are expected to produce about two thirds of the Brazilian demand for titanium pigment once the project reaches full capacity."
"For the next 20 years, there will be lots of exploration and development in a region where there are few roads and limited sea access. So, aviation will play a crucial role in the green transition."
"There is a huge economic benefit for companies to be able to get that incremental production, because they already have all the infrastructure in place, including people, permits and mills."
"Nuestro propósito para los próximos años es el uso de la tecnología y la automatización para no exponer a nuestros trabajadores en la línea de fuego y garantizar una operación eficiente y segura a nuestros clientes.”
"El objetivo de Epiroc es contar con alternativas eléctricas en todos nuestros equipos subterráneos para el 2025 y en los equipos de tajo abierto para el 2030."
"Our push towards sustainability is the common theme of all investments. We want to create a global network of integrated businesses with multiple synergies."
USA Mining 2025-26 pre-release is a snapshot capturing insights from over 70 executives and decision-makers across the value chain and from coast to coast, sharing not only how the industry is changing, but also where it is heading next.